Bicycle Therapeutics (BCYC)
(Delayed Data from NSDQ)
$22.73 USD
+0.21 (0.93%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $22.71 -0.02 (-0.09%) 4:22 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -1.26 |
EPS Last Quarter | -1.16 |
Last EPS Surprise | 5.69% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -5.20 |
Next Year | -5.82 |
EPS (TTM) | -5.13 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.11M | 7.33M | 33.24M | 32.76M |
# of Estimates | 5 | 5 | 6 | 6 |
High Estimate | 13.30M | 13.30M | 53.40M | 55.00M |
Low Estimate | 5.00M | 5.00M | 20.00M | 20.00M |
Year ago Sales | 4.90M | 11.40M | 26.98M | 33.24M |
Year over Year Growth Est. | 45.02% | -35.67% | 23.20% | -1.44% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.26 | -1.28 | -5.20 | -5.82 |
# of Estimates | 6 | 5 | 8 | 7 |
Most Recent Consensus | -1.36 | -1.43 | -5.85 | -5.55 |
High Estimate | -1.11 | -1.19 | -4.43 | -5.20 |
Low Estimate | -1.45 | -1.43 | -5.85 | -6.85 |
Year ago EPS | -1.30 | -1.41 | -5.08 | -5.20 |
Year over Year Growth Est. | 3.08% | 9.22% | -2.36% | -11.82% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.26 | -1.28 | -5.20 | -5.82 |
7 Days Ago | -1.26 | -1.28 | -5.20 | -5.82 |
30 Days Ago | -1.26 | -1.28 | -5.20 | -5.82 |
60 Days Ago | -1.26 | -1.28 | -5.20 | -5.82 |
90 Days Ago | -1.10 | -1.17 | -5.59 | -6.02 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.26 | -1.28 | -5.20 | -5.82 |
Zacks Consensus Estimate | -1.26 | -1.28 | -5.20 | -5.82 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.16 | -1.26 | -1.41 | -1.30 | NA |
Estimate | -1.23 | -1.06 | -1.10 | -1.06 | NA |
Difference | 0.07 | -0.20 | -0.31 | -0.24 | -0.17 |
Surprise | 5.69% | -18.87% | -28.18% | -22.64% | -16.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more